Position in RDNT
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$16,868,272
-$5,783,355 QoQ
Shares Held
301,812
-4.9% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $77,160,581 across 6 Diagnostics & Research names. RDNT ranks #3 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
232,222 | $21,450,346 | |
| 2 | VCYT |
Veracyte, Inc.
|
591,488 | $19,051,828 | |
| 3 | RDNT |
RadNet, Inc.
This page
|
301,812 | $16,868,272 | |
| 4 | NEO |
Neogenomics Inc
|
1,133,026 | $8,407,052 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
14,102 | $6,931,556 | |
| 6 | QGEN |
Qiagen N.V.
|
111,177 | $4,451,527 |
All Filings in RDNT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,868,272 | 301,812 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $22,651,627 | 317,472 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,116,460 | 368,934 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,177,452 | 319,407 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,177,937 | 265,043 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $14,443,121 | 206,803 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $14,542,894 | 209,582 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,019,669 | 119,139 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||